Skip to main content
Log in

Prevention of hypertension in DOCA-salt rats by an inhibitor of soluble expoxide hydrolase

Cell Biochemistry and Biophysics Aims and scope Submit manuscript

Abstract

Cyclooxygenase and lipoxygenase metabolism of arachidonic acid produces compounds important in cardiovascular diovascular control. Further, arachidonic acid can be metabolised by cytochrome p450 to produce epoxyeicosatrienoic acids (EETs). These derivatives are inactivated by soluble epoxide hydrolase (sEH). The potential role of these EETs in hypertension and cardiac remodelling has been determined using the selective sEH inhibitor, N-adamantyl-N′-dodecylurea (ADU), in deoxycorticosterone acetate (DOCA)-salt hypertensive rats. Experiments were performed on male Wistar rats following uninephrectomy alone (UNX rats) or uninephrectomy with administration of DOCA (25 mg every fourth day subcutaneously) and 1% NaCl in drinking water (DOCA-salt rats). ADU (10 mg/kg/d subcutaneously) was administered for 2wk starting 2wk after surgery. Cardiovascular structure and function were determined using organ wet weights, histological analysis of collagen and inflammation, isolated heart and thoracic aortic ring preparation, and electrophysiological measurements. DOCA-salt hypertensive rats developed hypertension, hypertrophy, perivascular and interstitial fibrosis, endothelial dysfunction, and prolongation of the cardiac action potential duration within 4 wk. Administration of ADU prevented the further increase in systolic blood pressure and left-ventricular wet weight and normalized endothelial function. ADU treatment did not change inflammatory cell infiltration, collagen deposition, or cardiac action potential duration. EETs may be involved in the development of hypertension and endothelial dysfunction in DOCA-salt rats, but not in excessive collagen deposition or electrophysiological abnormalities.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Fletcher, J. R. (1993) Eicosanoids. Critical agents in the physiological process and cellular injury. Arch Surg. 128, 1192–1196.

    PubMed  CAS  Google Scholar 

  2. Roman, R. J. (2002) P-450 metabolites of arachidonic acid in the control of cardiovascular function. Physiol Rev. 82, 131–185.

    PubMed  CAS  Google Scholar 

  3. Capdevila, J. H. and Falck, J. R. (2001) the CYP P450 arachidonic acid monooxygenases: from cell signaling to blood pressure regulation. Biochem Biophys Res Commun. 285, 571–576.

    Article  PubMed  CAS  Google Scholar 

  4. Wu, S., Chen, W., Murphy, E., et al. (1997) Molecular cloning, expression, and functional significance of a cytochrome P450 highly expressed in rat heart myocytes. J. Biol. Chem. 272, 12,551–12,559.

    CAS  Google Scholar 

  5. Node, K., Ruan, X. L., Dai, J., et al. (2001) Activation of Galpha s mediates induction of tissue-type plasminogen activator gene transcription by epoxyeicosatrienoic acids. J. Biol. Chem. 276, 15,983–15,989.

    Article  CAS  Google Scholar 

  6. Sun, J., Sui, X., Bradbury, J. A., Zeldin, D. C., Conte, M. S., and Liao, J. K. (2002) Inhibition of vascular smooth muscle cell migration by cytochrome p450 epoxygenase-derived eicosanoids. Circ. Res. 90, 1020–1027.

    Article  PubMed  CAS  Google Scholar 

  7. Node, K., Huo, Y., Ruan, X., et al. (1999) Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids. Science 285, 1276–1279.

    Article  PubMed  CAS  Google Scholar 

  8. Muthalif, M. M., Karzoun, N. A., Gaber, L., et al. (2000) Angiotensin II-induced hypertension: contribution of Ras GTPase/Mitogen-activated protein kinase and cytochrome P450 metabolites. Hypertension 36, 604–609.

    PubMed  CAS  Google Scholar 

  9. Messer-Letienne, I., Bernard, N., Roman, R. J., Sassard, J., and Benzoni, D. (1999) Cytochrome P-450 arachidonate metabolite inhibition improves renal function in Lyon hypertensive rats. Am. J. Hypertens. 12, 398–404.

    Article  PubMed  CAS  Google Scholar 

  10. Sacerdoti, D., Escalante, B., Abraham, N. G., McGiff, J. C., Levere, R. D., and Schwartzman, M. L. (1989) Treatment with tin prevents the development of hypertension in spontaneously hypertensive rats. Science 243, 388–390.

    Article  PubMed  CAS  Google Scholar 

  11. Stec, D. E., Deng, A. Y., Rapp, J. P., and Roman, R. J. (1996) Cytochrome P450 4A genotype cosegregates with hypertension in Dahl S rats. Hypertension 27, 564–568.

    PubMed  CAS  Google Scholar 

  12. Lapuerta, L., Chacos, N., Falck, J. R., Jacobson, H., and Capdevila, J. H. (1988) Renal microsomal cytochrome P-450 and the oxidative metabolism of arachidonic acid. Am. J. Med. Sci. 295, 275–279.

    Article  PubMed  CAS  Google Scholar 

  13. Capdevila, J. H., Wei, S., Yan, J., et al. (1992) Cytochrome P-450 arachidonic acid epoxygenase. Regulatory control of the renal epoxygenase by dietary salt loading. J Biol Chem. 267, 21,720–21,726.

    CAS  Google Scholar 

  14. Makita, K., Takahashi, K., Karara, A., Jacobson, H. R., Falck, J. R., and Capdevila, J. H. (1994) Experimental and/or genetically controlled alterations of the renal microsomal cytochrome P450 epoxygenase induce hypertension in rats fed a high salt diet. J Clin Invest. 94, 2414–2420.

    PubMed  CAS  Google Scholar 

  15. Holla, V. R., Makita, K., Zaphiropoulos, P. G., and Capdevila, J. H. (1999) The kidney cytochrome P-450 2C23 arachidonic acid epoxygenase is upregulated during dietary salt loading. J Clin Invest. 104, 751–760.

    PubMed  CAS  Google Scholar 

  16. Takahashi, K., Harris, R. C., Capdevila, J. H., et al. (1993) Induction of renal arachidonate cytochrome P-450 epoxygenase after uninephrectomy: counterregulation of hyperfiltration. J. Am. Soc. Nephrol. 3, 1496–1500.

    PubMed  CAS  Google Scholar 

  17. Morisseau, C., Goodrow, M. H., Dowdy, D., et al. (1999) Potent urea and carbamate inhibitors of soluble epoxide hydrolases. Proc. Natl. Acad. Sci. USA 96, 8849–8854.

    Article  PubMed  CAS  Google Scholar 

  18. Davis, B. B., Thompson, D. A., Howard, L. L., Morisseau, C., Hammock, B. D., and Weiss, R. H. (2002) Inhibitors of soluble epoxide hydrolase attenuate vascular smooth muscle cell proliferation. Proc. Natl. Acad. Sci. USA 99, 2222–2227.

    Article  PubMed  CAS  Google Scholar 

  19. Imig, J. D., Zhao, X., Capdevila, J. H., Morisseau, C., and Hammock, B. D. (2002) Soluble epoxide hydrolase inhibition lowers arterial blood pressure in angiotensin II hypertension. Hypertension 39, 690–694.

    Article  PubMed  CAS  Google Scholar 

  20. Yu, Z., Davis, B. B., Morisseau, C., et al. (2004) Vascular localization of soluble epoxide hydrolase in the human kidney. Am. J. Physiol. Renal. Physiol. 286, F720-F726.

    Article  PubMed  CAS  Google Scholar 

  21. Yu, Z., Xu, F., Huse, L. M., et al. (2000) Soluble epoxide hydrolase regulates hydrolysis of vasoactive epoxyeicosatrienoic acids. Circ. Res. 87, 992–998.

    PubMed  CAS  Google Scholar 

  22. Zhao, X., Yamamoto, T., Newman, J. W., et al. (2004) Soluble epoxide hydrolase inhibition protects the kidney from hypertension-induced damage. J. Am. Soc. Nephrol. 15, 1244–1253.

    PubMed  CAS  Google Scholar 

  23. Brown, L., Duce, B., Miric, G., and Sernia, C. (1999) Reversal of cardiac fibrosis in deoxycorticosterone acetate-salt hypertensive rats by inhibition of the reninangiotensin system. J. Am. Soc. Nephrol. 10(Suppl 11), S143-S148.

    PubMed  CAS  Google Scholar 

  24. Miric, G., Dallemagne, C., Endre, Z., Margolin, S., Taylor, S. M., and Brown, L. (2001) Reversal of cardiac and renal fibrosis by pirfenidone and spironolactone in streptozotocin-diabetic rats. Br. J. Pharmacol. 133, 687–694.

    Article  PubMed  CAS  Google Scholar 

  25. Smith, K. R., Pinkerton, K. E., Watanabe, T., Pedersen, T. L., Ma, S. J., and Hammock, B. D. (2005) Attenuation of tobacco smoke-induced lung inflammation by treatment with a soluble epoxide hydrolase inhibitor. Proc. Natl. Acad. Sci. USA 102, 2186–2191.

    Article  PubMed  CAS  Google Scholar 

  26. Sinal, C. J., Miyata, M., Tohkin, M., Nagata, K., Bend, J. R., and Gonzalez, F. J. (2000) Targeted disruption of soluble epoxide hydrolase reveals a role in blood pressure regulation. J. Biol. Chem. 275, 40,504–40,510.

    Article  CAS  Google Scholar 

  27. Hu, S., and Kim, H. S. (1993) Activation of K+ channel in vascular smooth muscles by cytochrome P450 metabolites of arachidonic acid. Eur. J. Pharmacol. 230, 215–221.

    Article  PubMed  CAS  Google Scholar 

  28. Satoh, T., Cohen, H. T., and Katz, A. I. (1993) Intracellular signaling in the regulation of renal Na−K-ATPase. II. Role of eicosanoids. J. Clin. Invest. 91, 409–415.

    Article  PubMed  CAS  Google Scholar 

  29. He, H., Podymow, T., Zimpelmann, J., and Burns, K. D. (2003) NO inhibits Na+−K+-2Cl-contransport via a cytochrome P-450-dependent pathway in renal epithelial cells (MMDD1). Am. J. Physiol. Renal Physiol. 284, F1235-F1244.

    PubMed  CAS  Google Scholar 

  30. Fornage, M., Hinojos, C. A., Nurowska, B. W., et al. (2002) Polymorphism in soluble epoxide hydrolase and blood pressure in spontaneously hypertensive rats. Hypertension 40, 485–490.

    Article  PubMed  CAS  Google Scholar 

  31. Catella, F., Lawson, J. A., Fitzgerald, D. J., and FitzGerald, G. A. (1990) Endogenous biosynthesis of arachidonic acid epoxides in humans: increased formation in pregnancy-induced hypertension. Proc. Natl. Acad. Sci. USA 87, 5893–5897.

    Article  PubMed  CAS  Google Scholar 

  32. Fornage, M., Boerwinkle, E., Doris, P. A., Jacobs, D., Liu, K., and Wong, N. D. (2004) Polymorphism of the soluble epoxide hydrolase is associated with coronary artery calcification in African-American subjects: The Coronary Artery Risk Development in Young Adults (CARDIA) study. Circulation 109, 335–339.

    Article  PubMed  CAS  Google Scholar 

  33. Sato, K., Emi, M., Ezura, Y., et al. (2004) Soluble epoxide hydrolase variant (Glu287 Arg) modifies plasma total cholesterol and triglyceride phenotype in familial hypercholesterolemia: intrafamilial association study in an eight-generation hyperlipidemic kindred. J Hum Genet. 49, 29–34.

    Article  PubMed  CAS  Google Scholar 

  34. Sheu, H. L., Omata, K., Utsumi, Y., et al. (1995) Epoxyeicosatrienoic acids stimulate the growth of vascular smooth muscle cells. Adv. Prostaglandin Thromboxane Leukot. Res. 23, 211–213.

    PubMed  CAS  Google Scholar 

  35. Karam, H., Heudes, D., Gonzales, M. F., Loffler, B. M., Clozel, M., and Clozel, J. P. (1996) Respective role of humoral factors and blood pressure in aortic remodeling of DOCA hypertensive rats. Am. J. Hypertens. 9, 991–998.

    Article  PubMed  CAS  Google Scholar 

  36. Owens, G. K., Rabinovitch, P. S., and Schwartz, S. M. (1981) Smooth muscle cell hypertrophy versus hyperplasia in hypertension. Proc. Natl. Acad. Sci. USA 78, 7759–763.

    Article  PubMed  CAS  Google Scholar 

  37. Konishi, M., and Su, C. (1983) Role of endothelium in dilator responses of spontaneously hypertensive rat arteries. Hypertension 5, 881–886.

    PubMed  CAS  Google Scholar 

  38. Luscher, T. F., Raij, L., and Vanhoutte, P. M. (1987) Endothelium-dependent vascular responses in normotensive and hypertensive Dahl rats. Hypertension 9, 157–163.

    PubMed  CAS  Google Scholar 

  39. Van de Voorde, J., and Leusen, I. (1986) Endothelium-dependent and independent relaxation of aortic rings from hypertensive rats. Am J Physiol. 250, H711-H717.

    PubMed  Google Scholar 

  40. Nunes, V. W., Fortes, Z. B., Nigro, D., Carvalho, M. H., Zorn, T. M., and Scivoletto, R. (2000) Influence of enalapril on the endothelial function of DOCA-salt hypertensive rats. Gen. Pharmacol. 34, 117–125.

    Article  PubMed  CAS  Google Scholar 

  41. Weintraub, N. L., Fang, X., Kaduce, T. L., VanRollins, M., Chatterjee, P., and Spector, A. A. (1999) Epoxide hydrolases regulate epoxyeicosatrienoic acid incorporation into coronary endothelial phospholipids. Am. J. Physiol. 277, H2098-H2108.

    PubMed  CAS  Google Scholar 

  42. Coulombe, A., Momtaz, A., Richer, P., Swynghedauw, B., and Coraboeuf, E. (1994) Reduction of calcium-independent transient outward potassium current density in DOCA salt hypertrophied rat ventricular myocytes. Pflugers Arch. 427, 47–55.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Lindsay Brown.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Loch, D., Hoey, A., Morisseau, C. et al. Prevention of hypertension in DOCA-salt rats by an inhibitor of soluble expoxide hydrolase. Cell Biochem Biophys 47, 87–97 (2007). https://doi.org/10.1385/CBB:47:1:87

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1385/CBB:47:1:87

Index Entries

Navigation